These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36634200)

  • 1. Barriers to palliative care in hepatocellular carcinoma: A review of the literature.
    Abasseri M; Hoque S; Slavica Kochovska BA; Caldwell K; Sheahan L; Zekry A
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1047-1055. PubMed ID: 36634200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A narrative review of supportive and end of life care considerations in advanced hepatocellular carcinoma.
    Hashmi IN; Lee HM; Wedd JP; Sterling RK; Dulong-Rae TE; Cassel JB; Cyrus JW; Fletcher JJ; Noreika DM
    Ann Palliat Med; 2023 Nov; 12(6):1260-1274. PubMed ID: 37691333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of Liver and Palliative Care Clinicians toward Specialist Palliative Care Consultation for Patients with End-Stage Liver Disease.
    Esteban JPG; Rein L; Szabo A; Saeian K; Rhodes M; Marks S
    J Palliat Med; 2019 Jul; 22(7):804-813. PubMed ID: 30892126
    [No Abstract]   [Full Text] [Related]  

  • 4. Socioeconomic and racial/ethnic disparities in receipt of palliative care among patients with metastatic hepatocellular carcinoma.
    Alterio RE; Ju MR; Wang SC; Mansour JC; Yopp A; Porembka MR
    J Surg Oncol; 2021 Dec; 124(8):1365-1372. PubMed ID: 34505295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Misconceptions of Palliative Care Among Patients With Hepatocellular Carcinoma: A Pilot Study.
    Abasseri M; Hoque S; Caldwell K; Sheahan L; Kochovska S; Agar M; Zekry A
    Am J Hosp Palliat Care; 2024 Aug; ():10499091241268423. PubMed ID: 39157978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults.
    Woodrell CD; Hansen L; Schiano TD; Goldstein NE
    Clin Ther; 2018 Apr; 40(4):512-525. PubMed ID: 29571567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inpatient Specialty-Level Palliative Care Is Delivered Late in the Course of Hepatocellular Carcinoma and Associated With Lower Hazard of Hospital Readmission.
    Woodrell CD; Goldstein NE; Moreno JR; Schiano TD; Schwartz ME; Garrido MM
    J Pain Symptom Manage; 2021 May; 61(5):940-947.e3. PubMed ID: 33035651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative medicine referrals for hepatocellular carcinoma: a national survey of gastroenterologists.
    Sabih AH; Laube R; Strasser SI; Lim L; Cigolini M; Liu K
    BMJ Support Palliat Care; 2021 Mar; ():. PubMed ID: 33737287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Knowledge, Barriers to Implementation, and Future Directions in Palliative Care for End-Stage Liver Disease.
    Fricker ZP; Serper M
    Liver Transpl; 2019 May; 25(5):787-796. PubMed ID: 30758901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative care in hepatocellular carcinoma.
    Laube R; Sabih AH; Strasser SI; Lim L; Cigolini M; Liu K
    J Gastroenterol Hepatol; 2021 Mar; 36(3):618-628. PubMed ID: 32627853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease.
    Ufere NN; Donlan J; Waldman L; Dienstag JL; Friedman LS; Corey KE; Hashemi N; Carolan P; Mullen AC; Thiim M; Bhan I; Nipp R; Greer JA; Temel JS; Chung RT; El-Jawahri A
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2592-2599. PubMed ID: 30885884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial.
    Verma M; Kalman R; Horrow J; Gallagher M; Woodrell C; Navarro V
    J Palliat Med; 2023 Mar; 26(3):334-341. PubMed ID: 36149682
    [No Abstract]   [Full Text] [Related]  

  • 13. The incompatibility of healthcare services and end-of-life needs in advanced liver disease: A qualitative interview study of patients and bereaved carers.
    Hudson B; Hunt V; Waylen A; McCune CA; Verne J; Forbes K
    Palliat Med; 2018 May; 32(5):908-918. PubMed ID: 29393806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Implementation of Palliative and Supportive Care in Hepatocellular Carcinoma.
    Gofton C; Agar M; George J
    Semin Liver Dis; 2022 Nov; 42(4):514-530. PubMed ID: 36193677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.
    Walling AM; Schreibeis-Baum H; Pimstone N; Asch SM; Robinson L; Korlekar S; Lorenz K; Nwajuaku T; Rosenfeld K
    J Palliat Med; 2015 Apr; 18(4):378-81. PubMed ID: 25493552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative treatment in advanced hepatocellular carcinoma: has it made any difference?
    Paul SB; Manjunatha YC; Acharya SK
    Trop Gastroenterol; 2009; 30(3):125-34. PubMed ID: 20306740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative Care in a Death-Denying Culture: Exploring Barriers to Timely Palliative Efforts for Heart Failure Patients in the Primary Care Setting.
    Crimmins RM; Elliott L; Absher DT
    Am J Hosp Palliat Care; 2021 Jan; 38(1):77-83. PubMed ID: 32319317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome.
    Dalgaard KM; Bergenholtz H; Nielsen ME; Timm H
    Palliat Support Care; 2014 Dec; 12(6):495-513. PubMed ID: 24621947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Zou WY; El-Serag HB; Sada YH; Temple SL; Sansgiry S; Kanwal F; Davila JA
    Dig Dis Sci; 2018 May; 63(5):1173-1181. PubMed ID: 29508165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
    Davila JA; Duan Z; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.